E2A and pre-B cell acute lymphoblastic leukemias (ALL)
Download
Report
Transcript E2A and pre-B cell acute lymphoblastic leukemias (ALL)
E2A and acute
lymphoblastic
leukemias (ALL)
A closer look at the E2A gene...
Other names: TCF3, ITF1, and Factors
E12/E47
Located on chromosome 19
Encodes two proteins: E12 and E47
17 exons
E2A
What are the E2A proteins?
Transcription factors
Members of the basic helix-loop-helix (bHLH)
superfamily
Necessary for forming protein dimers and making
contact with DNA
Bind to consensus E-box sequence sites
Mouse Models...
E2A -/- mutants develop to full term without
apparent abnormalities
High rate of postnatal death
Show retarded postnatal growth
Contain no B cells while T-cell, macrophage,
granulocyte, and erythroid lineages are intact
What about E2A +/- mice?
Have half as many B-cells as wild-type
embryos
Suggests levels of E2A expression in cell
translates into levels of B-cells!
Roles of E2A in B-cell Differentiation:
Induces expression of other lineage-specific
transcription factors (including EBF and RAG
proteins)
Collaborates with EBF to regulate expression of
other B-lineage genes
Regulates immunoglobulin gene recombination
by facilitating access of RAG recombinase to
recombination loci
E2A plays a similar role in T-cell
development...
E2A-HEB heterodimers contribute to the
regulation of CD4 expression
Plays important roles in recombination of T-cell
receptor
Provides survival signal for immature T-cells
Proposed to also have many negative affects on
T-cell development (not well understood)
E2A’s role in Leukemia formation
Chromosomal translocation t(1:19) creates a
fusion protein E2A-PBX1
Fusion protein combines the activator domains
of E2A with the DNA-binding homeodomain
region of PBX1
Fusion protein retains ability to interact with
HOX proteins to activate transcription
Two things to consider:
The effect of E2A heterozygosity on tumor
development( especially considering E2A
as a tumor suppressor)
The E2A-PBX1 fusion protein: novel
biochemical properties and functional
activities
E2A as a tumor suppressor...
Displacement of section of PBX1 by
the activator domains of E2A could...
Increase PBX1 ability to activate
transcription
E2A-PBX1 localized to the nucleus
Affect the ability of inhibitor proteins to bind
to PBX1
Downstream Targets
EB-1: encodes a phosphotyrosine-binding
domain protein, and as such may have a role in
the regulation of cell proliferation
Wnt16: encodes a member of the WNT/WG
family of growth factors; members of this family
have been identified as potent activators of
growth and differentiation
Acute Lymphoblastic Leukemia
(ALL)
Most common form of childhood cancer
Undifferentiated lymphoid cells accumulate in bone
marrow, replace normal blood cells, and spread to other
parts of the body
~3,000 children are diagnosed each year
Peak incidence from 3-5 years of age
98-99% of children diagnosed early attain initial
complete remissions
Approximately 80% of patients can be cured
Treatment Options
Chemotherapy
Hematopoietic Stem Cell Transplant for
high-risk cases
Current Research
Optimize dosage and scheduling of
antileukemic agents based on patient’s
leukemic cell genetic features
Microarray technology to obtain a profile of gene
and protein expression in leukemia cells
Safety of stem cell transplant and increase the
number of donors
References
St. Jude Children’s Research Hospital “Acute Lymphoblastic Leukemia”
http://www.stjude.org/diseasesummaries/0,2557,449_2165_2987,00.html
Atlas of Genetics and Cytogenetics in Oncology and Hematology
http://www.infobiogen.fr/services/chromcancer/Genes/E2A.html
Cooper, G.M. The Cell: A molecular approach
http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=cooper.figgrp.837
Aspland, S.E. et al. 2001. The role of E2A-PBX1 in leukemogenesis.
Oncogene 20: 5708-5717.
Zhuang, Yuan et al. 1994. The helixl-loop-helix gene E2A is required for B cell
formation. Cell 79: 875-884.
Greenbaum, Stephen and Yuan Zhuang. 2002. Regulation of early lymphocyte
development by E2A family proteins. Seminars in Immunology 14(6):405414.
Schebesta, Michael et al. 2002. Transcriptional control of B-cell development.
Current Opinion in Immunology 14: 216-223.
http://www.cella.cn/book/13/images/image021.jpg